# Northwestern Medicine Central DuPage Hospital – FDA Inspection, Feb 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/e45bd9ec-388e-4116-b336-5adde572dccb
Source feed: FDA_Inspections

> FDA inspection 1081078 of Northwestern Medicine Central DuPage Hospital, February 22, 2019. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081078
- Company Name: Northwestern Medicine Central DuPage Hospital
- Inspection Date: 2019-02-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 1246188 - 2024-08-07
- FDA Inspection 1122292 - 2020-02-04
- FDA Inspection 985177 - 2015-12-22
- [FDA Inspection 610717 - 2009-08-24](https://www.keypedia.com/records/fda_inspections/northwestern-medicine-central-dupage-hospital/31bfe2af-e0df-4816-abfb-2a1ebc8705ee)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/adam-j-taylor/a6e86ebd-4079-4c56-9129-8574e42ef75c)
- [FDA Associated Person](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8)

Company: https://www.keypedia.com/companies/northwestern-medicine-central-dupage-hospital/d04451ef-7604-49a5-8df5-97b5adb87b96

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
